A Day Up For Calidi Biotherapeutics, Inc.
Wed, Jul 09, 2025 at 07:14 PM
Calidi Biotherapeutics, Inc. (CLDI:NYSEMKT) rocketted at $0.7, a gain of 109%. On Wed, Jul 09, 2025, CLDI:NYSEMKT touched a New 2-Week High of $0.7. The stock appeared on our News Catalysts scanner on Wed, Jul 09, 2025 at 05:38 PM in the 'AGREEMENT' category. From Wed, Jun 25, 2025, the stock recorded 44.44% Up Days and 30.00% Green Days
The stock spiked on Wed, Jul 09, 2025 at $1.6 with a volume of 615M+.
About Calidi Biotherapeutics, Inc. (CLDI:NYSEMKT)
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
Top 10 Gainers:
- Hempacco Co., Inc. (HPCO:NASDAQ), 250%
- SU Group Holdings Limited (SUGP:NASDAQ), 171.41%
- Evoke Pharma, Inc. (EVOK:NASDAQ), 162.78%
- Calidi Biotherapeutics, Inc. (CLDI:NYSEMKT), 108.96%
- Basel Medical Group Ltd (BMGL:NASDAQ), 98.9%
- Scage Future (SCAG:NASDAQ), 56.67%
- EpicQuest Education Group International Limited (EEIQ:NASDAQ), 49.89%
- Eyenovia, Inc. (EYEN:NASDAQ), 49.81%
- SeaChange International, Inc. (SEAC:NASDAQ), 48.94%
- SHF Holdings, Inc. (SHFS:NASDAQ), 46.38%